Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by BrigatinibNeoplasms by Site, Thoracic Neoplasms, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 22026-04-29NCT06620835

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Groupe Francais De Pneumo-Cancerologie7

27 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre François BaclesseCaenFrance23
Centre Georges-François LeclercDijonFrance15
Centre Hospitalier de Villefranche sur SaoneVillefranche-sur-SaôneFrance4
Centre Leon BérardLyonFrance2
Centre Paul StraussStrasbourgFrance7
CH AnnecyÉpagnyFrance1
CH Bretagne AtlantiqueVannesFrance7
CH Métropole-SavoieChambéryFrance2
CHD les OudariesLa Roche-sur-YonFrance1
CHRU de NancyNancyFrance14
CHU de Bordeaux Haut LévêquePessacFrance1
CHU de BrestBrestFrance18
CHU de la RéunionSaint-PierreFrance2
CHU de NîmesNîmesFrance28
CHU DupuytrenLimogesFrance13
CHU OrléansOrléansFrance4
CHU PonchaillouxRennesFrance1
CHU Rennes, Hôpital PontchaillouRennesFrance2
CLCC Antoine LacassagneNiceFrance1
HIA St AnneToulonFrance1
Hôpital Charles NicolleRouenFrance11
Hôpital Louis PasteurColmarFrance1
Hôpital NordMarseilleFrance8
Hôpital TenonParisFrance19
Pneumologie Centre Hospitalier Intercommunal de CréteilCréteilFrance4